![](/img/cover-not-exists.png)
A Pilot, 15-month, randomised effectiveness trial of Risperidone long-acting injection (RLAI) versus oral atypical antipsychotic agents (AAP) in persons with bipolar disorder
K. N. Roy Chengappa, Scott R. Turkin, Patricia J. Schlicht, Sherry L. Murphy, Jaspreet S. Brar, Andrea Fagiolini, Patricia R. Houck, Ronald G. Garbutt, Noreen FredrickVolume:
22
Year:
2010
Language:
english
Pages:
13
DOI:
10.1111/j.1601-5215.2010.00458.x
File:
PDF, 612 KB
english, 2010